Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel D Stern

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
NPJ Digital Medicine|April 15, 2020
Quantifying the use of connected digital products in clinical researchCaroline Marra, Jacqueline L Chen, Andrea Coravos, et al.
Health Affairs (Project Hope)|July 1, 2024
FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development TimeKathleen L Miller, Ariel D Stern, Aaron Kearsley, et al.
The New England Journal of Medicine|April 14, 2021
Remote Patient Monitoring - Overdue or Overused?Keizra Mecklai, Nicholas Smith, Ariel D Stern, et al.
International Journal of Technology Assessment in Health Care|November 16, 2023
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluationJan B Brönneke, Annika Herr, Simon Reif, et al.
JAMA Network Open|March 18, 2024
Differences in Care Team Response to Patient Portal Messages by Patient Race and EthnicityMitchell Tang, Rebecca G Mishuris, Lily Payvandi, et al.
NPJ Digital Medicine|June 17, 2026
Two decades of growth and trends in the FDA authorization of digital medical devicesAlexander O Everhart, Cirrus Foroughi, Melissa Ouellet, et al.
Health Affairs (Project Hope)|July 8, 2020
Lessons From The Impact Of Price Regulation On The Pricing Of Anticancer Drugs In GermanyVictoria D Lauenroth, Aaron S Kesselheim, Ameet Sarpatwari, et al.
Npj Mental Health Research|November 26, 2025
FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challengesJulian Herpertz, Ariel D Stern, Nils Opel, et al.
Fertility and Sterility|April 3, 2016
Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic tripletsMalinda S Lee, Brady T Evans, Ariel D Stern, et al.
Health Affairs (Project Hope)|July 2, 2019
The Impact Of Price Regulation On The Availability Of New Drugs In GermanyAriel D Stern, Felicitas Pietrulla, Annika Herr, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
NPJ Digital Medicine|April 15, 2020
Quantifying the use of connected digital products in clinical researchCaroline Marra, Jacqueline L Chen, Andrea Coravos, et al.
Health Affairs (Project Hope)|July 1, 2024
FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development TimeKathleen L Miller, Ariel D Stern, Aaron Kearsley, et al.
The New England Journal of Medicine|April 14, 2021
Remote Patient Monitoring - Overdue or Overused?Keizra Mecklai, Nicholas Smith, Ariel D Stern, et al.
International Journal of Technology Assessment in Health Care|November 16, 2023
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluationJan B Brönneke, Annika Herr, Simon Reif, et al.
JAMA Network Open|March 18, 2024
Differences in Care Team Response to Patient Portal Messages by Patient Race and EthnicityMitchell Tang, Rebecca G Mishuris, Lily Payvandi, et al.
NPJ Digital Medicine|June 17, 2026
Two decades of growth and trends in the FDA authorization of digital medical devicesAlexander O Everhart, Cirrus Foroughi, Melissa Ouellet, et al.
Health Affairs (Project Hope)|July 8, 2020
Lessons From The Impact Of Price Regulation On The Pricing Of Anticancer Drugs In GermanyVictoria D Lauenroth, Aaron S Kesselheim, Ameet Sarpatwari, et al.
Npj Mental Health Research|November 26, 2025
FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challengesJulian Herpertz, Ariel D Stern, Nils Opel, et al.
Fertility and Sterility|April 3, 2016
Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic tripletsMalinda S Lee, Brady T Evans, Ariel D Stern, et al.
Health Affairs (Project Hope)|July 2, 2019
The Impact Of Price Regulation On The Availability Of New Drugs In GermanyAriel D Stern, Felicitas Pietrulla, Annika Herr, et al.
Pageof 4